33 related articles for article (PubMed ID: 19694701)
1. Lessons learned from successful Papanicolaou cytology cervical cancer prevention in the Socialist Republic of Vietnam.
Suba EJ; Raab SS
Diagn Cytopathol; 2012 Apr; 40(4):355-66. PubMed ID: 21394935
[TBL] [Abstract][Full Text] [Related]
2. Self-collected Pap smears may provide an acceptable and effective method of cervical cancer screening.
Singla AA; Komesaroff P
Health Sci Rep; 2018 May; 1(5):e33. PubMed ID: 30623069
[TBL] [Abstract][Full Text] [Related]
3. Cervical premalignant lesions and their management.
Köse FM; Naki MM
J Turk Ger Gynecol Assoc; 2014; 15(2):109-21. PubMed ID: 24976778
[TBL] [Abstract][Full Text] [Related]
4. Updates of the current screening guidelines for the early detection of cervical cancer.
Hong JH; Lee JK
J Gynecol Oncol; 2013 Jul; 24(3):212-4. PubMed ID: 23875069
[No Abstract] [Full Text] [Related]
5. Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years.
Creighton P; Lew JB; Clements M; Smith M; Howard K; Dyer S; Lord S; Canfell K
BMC Public Health; 2010 Nov; 10():734. PubMed ID: 21110881
[TBL] [Abstract][Full Text] [Related]
6. [Management of CIN1].
Rouzier R
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S114-20. PubMed ID: 18191500
[TBL] [Abstract][Full Text] [Related]
7. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening with liquid cytology in women with developmental disabilities.
Kavoussi SK; Smith YR; Ernst SD; Quint EH
J Womens Health (Larchmt); 2009; 18(1):115-8. PubMed ID: 19072727
[TBL] [Abstract][Full Text] [Related]
9. Cytological reporting of cervical abnormalities according to endocervical status.
Mitchell H; Medley G
Br J Cancer; 1993 Mar; 67(3):585-8. PubMed ID: 8439508
[TBL] [Abstract][Full Text] [Related]
10. Risk of high-grade cervical dysplasia and gynaecological malignancies following the cytologic diagnosis of atypical endocervical cells of undetermined significance: a retrospective study of a state-wide screening population in Western Australia.
Munro A; Williams V; Semmens J; Leung Y; Stewart CJ; Codde J; Spilsbury K; Steel N; Cohen P; O'leary P
Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):268-73. PubMed ID: 26044565
[TBL] [Abstract][Full Text] [Related]
11. Utility of Endocervical Sampling at Time of Colposcopy when Referral Cytology Is Low Grade or Better.
Pierson RC; Johnson BE; Voirol JR; Kasper KM
Reprod Sci; 2020 Jan; 27(1):55-60. PubMed ID: 32046412
[TBL] [Abstract][Full Text] [Related]
12. Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia.
Huang A; Quinn M; Tan J
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):426-8. PubMed ID: 19694701
[TBL] [Abstract][Full Text] [Related]
13. Cervical screening and human papillomavirus.
Sheary B; Dayan L
Aust Fam Physician; 2005 Jul; 34(7):578-80. PubMed ID: 15999169
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
